Search

Search Constraints

You searched for: Author/Creator Shah, Mirat

Search Results

1. A Phase I Study of Dinaciclib in Combination With MK‐2206 in Patients With Advanced Pancreatic Cancer. Issue 6 (1st August 2020)

3. Improving Dose-Optimization Processes Used in Oncology Drug Development to Minimize Toxicity and Maximize Benefit to Patients. Issue 30 (20th October 2022)